Therapeutic Drug Monitoring (TDM)

A Randomized, Controlled Trial of Therapeutic Drug Monitoring in Treatment-Naive and Experienced HIV Patients - 12/11/07


Therapeutic Drug Monitoring of Boosted Tipranavir with and without Combination to Lopinavir or Fosamprenavir - 3/17/06

Study of Possible Drug-drug Interactions between Tenofovir and Nevirapine and Efavirenz in HIV patients - 1/17//06

Prediction of Neuropsychiatric Adverse Events Associated with Long-term Efavirenz Therapy Using Plasma Drug Level Monitoring - 10/28/05

Therapeutic Drug Monitoring (TDM) Often Brings Clinical Benefits - 9/23/05

Pharmacokinetic Interaction between Chemotherapy for Non-Hodgkin's Lymphoma and Protease Inhibitors in HIV Patients - 6/24/05

Lopinavir/ritonavir Combination and Total/HDL Cholesterol Ratio - 4/04/05

Integrating Testing for Resistance, Viral Fitness and Drug Levels into Clinical Practice - 11/22/04

Simplification of Therapeutic Drug Monitoring for Twice-Daily Regimens of Lopinavir/Ritonavir  - 10/04/04

GENOPHAR: A Randomized Study of Plasma Drug Measurements in Association with Genotypic Resistance Testing and Expert Advice to Optimize Therapy - 09/24/04

Lopinavir-Ritonavir Dose Adjustment and Therapeutic Drug Monitoring and Monitoring of Liver Function May Allow Concomitant Use of Rifampin in HIV Patients with Tuberculosis - 06/18/04

Therapeutic Drug Monitoring (TDM) Reveals Lower Levels of Lopinavir/Ritonavir When Given with Efavirenz or Nevirapine - 03/31/04

FDA Approves Roche Diagnostics Test for Use in Screening Source Plasma and Organ Donors for HIV-1 - 03/05/04

Therapeutic Drug Monitoring of the HIV/AIDS Drugs Abacavir, Zidovudine, Efavirenz, Nevirapine, Indinavir, Lopinavir, and Nelfinavir - 11/27/02

Therapeutic Drug Monitoring: Will It Ever Be a Useful Clinical Tool? - 11/22/02